ARCHIVES

IDMC Halts Mekinist-Tafinlar Trial Early Due to OS Benefit; Recommends Crossover

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Approves Velcade Injection In Mantle Cell Lymphoma

October 31, 2014

Amid Protests Over Grant Paylines, NCI’s Niederhuber Tells Scientists To Get “Leaner And Better”.

April 7, 2006

In Brief: Nobel Prize Awarded To Sharp, Roberts For Gene Splicing; ACS Fills Top Positions

October 22, 1993

Bush May Nominate Zerhouni For NIH Director

March 8, 2002

In Brief: Treatment Reorganization Will Give Rauscher “Lumps,” He Says; Coordinating Group Favored

August 16, 1974

Increase Cancer Center Grants More Than R01s, SPOREs, Report Tells NCI

February 28, 2003